期刊
FUTURE MEDICINAL CHEMISTRY
卷 5, 期 14, 页码 1647-1660出版社
FUTURE SCI LTD
DOI: 10.4155/fmc.13.126
关键词
-
资金
- Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center
- Van Vleet Endowed Professorship
Cancer is a major devastating disease, and is a leading cause of death worldwide. Despite the progress in cancer treatment, cancer mortality rate remains high. Therefore, the discovery and development of improved anticancer drugs to treat cancer are needed. 4H-chromenes have strong cytotoxicity against a panel of human cancer cell lines involving pathways that include microtubule depolarization and tumor vasculature disruption. A chromene analog, Crolibulin (EPC2407) is currently in Phase I/II clinical trials for the treatment of advanced solid tumors. This article reviews the general synthesis, biological activities and structure-activity relatinships of different classes of chromenes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据